loadpatents
name:-0.016139030456543
name:-0.014593839645386
name:-0.00053501129150391
Morimoto; Chikao Patent Filings

Morimoto; Chikao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morimoto; Chikao.The latest application filed is for "cancer treatment composition combining anti-cd26 antibody and other anticancer agent".

Company Profile
0.13.14
  • Morimoto; Chikao - Tokyo JP
  • Morimoto; Chikao - Setagaya-ku JP
  • Morimoto; Chikao - Brookline MA
  • Morimoto; Chikao - Needham MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cancer treatment composition combining anti-CD26 antibody and other anticancer agent
Grant 11,273,217 - Yamada , et al. March 15, 2
2022-03-15
Cancer Treatment Composition Combining Anti-cd26 Antibody And Other Anticancer Agent
App 20180326052 - YAMADA; Taketo ;   et al.
2018-11-15
Anti-human CD26 monoclonal antibody or antigen-binding fragment thereof
Grant 9,920,135 - Morimoto , et al. March 20, 2
2018-03-20
Anti-human Cd26 Monoclonal Antibody Or Antigen-binding Fragment Thereof
App 20160159925 - MORIMOTO; Chikao ;   et al.
2016-06-09
Method of treating malignant mesothelioma
Grant 8,771,688 - Morimoto , et al. July 8, 2
2014-07-08
Method of treating malignant mesothelioma
App 20140004103 - Morimoto; Chikao ;   et al.
2014-01-02
Anti-CD26 antibodies and methods of use thereof
Grant 8,030,469 - Aoyagi , et al. October 4, 2
2011-10-04
Method Of Treating Malignant Mesothelioma
App 20100135993 - Morimoto; Chikao ;   et al.
2010-06-03
Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof
Grant 7,704,686 - Morimoto , et al. April 27, 2
2010-04-27
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
Grant 7,658,923 - Dang , et al. February 9, 2
2010-02-09
Anti-cd26 Antibodies And Methods Of Use Thereof
App 20090136523 - Aoyagi; Teikichi ;   et al.
2009-05-28
Anti-CD26 antibodies and methods of use thereof
Grant 7,462,698 - Aoyagi , et al. December 9, 2
2008-12-09
Compositions for Cancer Prevention, Treatment, or Amelioration Comprising Papaya Extract
App 20080069907 - Morimoto; Chikao ;   et al.
2008-03-20
Methods of Identifying Immunoregulatory Agents, Immunoregulatory Agents, and Uses Thereof
App 20070259824 - Morimoto; Chikao ;   et al.
2007-11-08
Anti-cd26 Monoclonal Antibodies As Therapy For Diseases Associated With Cells Expressing Cd26
App 20070207143 - Dang; Nam Hoang ;   et al.
2007-09-06
Anti-CD26 antibodies and methods of use thereof
App 20070105771 - Aoyagi; Teikichi ;   et al.
2007-05-10
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.
Grant 7,198,788 - Dang , et al. April 3, 2
2007-04-03
Cd26-based therapies for cancers and immune disease
App 20060093553 - Dang; Nam Hoang ;   et al.
2006-05-04
Compounds capable of inhibiting immunocyte-related allergic immune reactions
App 20060003988 - Morimoto; Chikao
2006-01-05
Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases
App 20050123524 - Morimoto, Chikao ;   et al.
2005-06-09
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
App 20030031665 - Dang, Nam Hoang ;   et al.
2003-02-13
Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof
Grant 6,265,551 - Duke-Cohan , et al. July 24, 2
2001-07-24
Monoclonal antibody which distinguishes helper inducer and suppressor inducer CD4+ lymphocytes
Grant 5,120,642 - Schlossman , et al. June 9, 1
1992-06-09
Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes
Grant 5,002,869 - Schlossman , et al. March 26, 1
1991-03-26
Activation antigen
Grant 4,882,424 - Schlossman , et al. November 21, 1
1989-11-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed